Embolx

Embolx is an emerging commercial-stage medical device company in Silicon Valley, developing microcatheters for arterial embolization procedures. Embolx is committed to dramatically improving the treatment of a variety of conditions, including cancerous tumors, benign prostatic hyperplasia, and uterine fibroids. The Sniper® balloon occlusion microcatheter sets a new standard for precise embolic delivery and superior target filling by controlling pressure to direct blood flow while protecting non-target surrounding tissues. Embolx is a privately held company.